A detailed history of Red Spruce Capital, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Red Spruce Capital, LLC holds 32,715 shares of ABT stock, worth $3.4 Million. This represents 1.63% of its overall portfolio holdings.

Number of Shares
32,715
Previous 31,404 4.17%
Holding current value
$3.4 Million
Previous $3.57 Million 4.76%
% of portfolio
1.63%
Previous 1.71%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 02, 2024

BUY
$100.73 - $112.44 $132,057 - $147,408
1,311 Added 4.17%
32,715 $3.4 Million
Q1 2024

Apr 10, 2024

BUY
$109.52 - $120.96 $261,533 - $288,852
2,388 Added 8.23%
31,404 $3.57 Million
Q4 2023

Jan 05, 2024

BUY
$90.19 - $110.4 $343,804 - $420,844
3,812 Added 15.12%
29,016 $3.19 Million
Q3 2023

Oct 03, 2023

BUY
$95.53 - $114.62 $3,916 - $4,699
41 Added 0.16%
25,204 $2.44 Million
Q2 2023

Jul 05, 2023

BUY
$100.78 - $112.29 $22,675 - $25,265
225 Added 0.9%
25,163 $2.74 Million
Q1 2023

Apr 06, 2023

BUY
$96.86 - $114.01 $137,831 - $162,236
1,423 Added 6.05%
24,938 $2.53 Million
Q4 2022

Jan 03, 2023

BUY
$95.06 - $111.52 $73,291 - $85,981
771 Added 3.39%
23,515 $0
Q3 2022

Oct 03, 2022

BUY
$96.76 - $112.03 $88,438 - $102,395
914 Added 4.19%
22,744 $2.2 Million
Q2 2022

Jul 05, 2022

SELL
$102.07 - $123.37 $10,002 - $12,090
-98 Reduced 0.45%
21,830 $2.37 Million
Q1 2022

Apr 05, 2022

BUY
$114.02 - $139.04 $93,838 - $114,429
823 Added 3.9%
21,928 $2.6 Million
Q4 2021

Jan 03, 2022

BUY
$115.53 - $141.46 $19,871 - $24,331
172 Added 0.82%
21,105 $2.97 Million
Q3 2021

Oct 04, 2021

BUY
$116.66 - $129.06 $47,597 - $52,656
408 Added 1.99%
20,933 $2.47 Million
Q2 2021

Jul 06, 2021

BUY
$105.79 - $124.53 $37,978 - $44,706
359 Added 1.78%
20,525 $2.38 Million
Q1 2021

Apr 01, 2021

BUY
$108.84 - $128.23 $65,739 - $77,450
604 Added 3.09%
20,166 $2.42 Million
Q4 2020

Jan 04, 2021

SELL
$105.0 - $114.42 $194,355 - $211,791
-1,851 Reduced 8.64%
19,562 $2.14 Million
Q3 2020

Oct 02, 2020

SELL
$91.64 - $111.29 $3,207 - $3,895
-35 Reduced 0.16%
21,413 $2.33 Million
Q2 2020

Jul 02, 2020

BUY
$76.57 - $98.0 $18,606 - $23,814
243 Added 1.15%
21,448 $1.96 Million
Q1 2020

Apr 06, 2020

SELL
$62.82 - $91.86 $2,010 - $2,939
-32 Reduced 0.15%
21,205 $1.67 Million
Q4 2019

Jan 16, 2020

BUY
$78.51 - $87.4 $1.67 Million - $1.86 Million
21,237 New
21,237 $1.85 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $182B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Red Spruce Capital, LLC Portfolio

Follow Red Spruce Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Red Spruce Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Red Spruce Capital, LLC with notifications on news.